Back to Search
MICHAEL SKELTON, MD
MD
Emergency Medicine Physician
NPI: 1972966273IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
82786(GA)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE
Class of 2016
Research & Publications (20)
Effects of renal perfusion pressure on renal medullary hydrogen peroxide and nitric oxide production.
PMID 19433780·Hypertension·2009
4-observational
(+/-)3,4-Methylenedioxymethamphetamine (MDMA) dose-dependently impairs spatial learning in the morris water maze after exposure of rats to different five-day intervals from birth to postnatal day twenty.
PMID 19372692·Dev Neurosci·2009
7-preclinical
Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (+/-)-3,4-methylenedioxymethamphetamine (ecstasy) in rats.
PMID 19198809·Psychopharmacology (Berl)·2009
4-observational
Effects of (+)-methamphetamine on path integration and spatial learning, but not locomotor activity or acoustic startle, align with the stress hyporesponsive period in rats.
PMID 19136054·Int J Dev Neurosci·2009
7-preclinical
Comparative analysis of 1st, 2nd, and 4th year MD students' attitudes toward Complementary Alternative Medicine (CAM).
PMID 18799010·BMC Res Notes·2008
8-other
(+/-)-3,4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: a comparison of single vs once per week treatment for 5 weeks.
PMID 18674550·Neuropharmacology·2008
4-observational
Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in rats.
PMID 18513404·BMC Neurosci·2008
4-observational
Effects of neonatal (+)-methamphetamine on path integration and spatial learning in rats: effects of dose and rearing conditions.
PMID 18502078·Int J Dev Neurosci·2008
7-preclinical
Neurological deficits and glycosphingolipid accumulation in saposin B deficient mice.
PMID 18480170·Hum Mol Genet·2008
7-preclinical
Developmental effects of 3,4-methylenedioxymethamphetamine: a review.
PMID 18332674·Behav Pharmacol·2008
6-review
Short- and long-term effects of (+)-methamphetamine and (+/-)-3,4-methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment.
PMID 17996031·J Neurochem·2008
7-preclinical
(+)-Methamphetamine increases corticosterone in plasma and BDNF in brain more than forced swim or isolation in neonatal rats.
PMID 17992688·Synapse·2008
7-preclinical
Age-dependent effects of neonatal methamphetamine exposure on spatial learning.
PMID 17762523·Behav Pharmacol·2007
7-preclinical
Neonatal (+)-methamphetamine increases brain derived neurotrophic factor, but not nerve growth factor, during treatment and results in long-term spatial learning deficits.
PMID 17606327·Psychoneuroendocrinology·2007
7-preclinical
A case of oxaliplatin-related posterior reversible encephalopathy syndrome.
PMID 17311705·Clin Colorectal Cancer·2007
5-case
Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse.
PMID 17047665·Neuropsychopharmacology·2007
7-preclinical
Treatment with MDMA from P11-20 disrupts spatial learning and path integration learning in adolescent rats but only spatial learning in older rats.
PMID 17016706·Psychopharmacology (Berl)·2006
7-preclinical
Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood.
PMID 15945064·Synapse·2005
4-observational
Metyrapone attenuates the sequential learning deficits but not monoamine depletions following d,l-fenfluramine administration to adult rats.
PMID 15484208·Synapse·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1230 BAXTER ST
ATHENS, GA 30606 - Phone
- (205) 934-3640
Quick Facts
- NPI
- 1972966273
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile